17.35
price up icon3.34%   0.56
after-market 시간 외 거래: 17.39 0.04 +0.23%
loading
전일 마감가:
$16.79
열려 있는:
$17.05
하루 거래량:
376.59K
Relative Volume:
1.55
시가총액:
$455.09M
수익:
$31.38M
순이익/손실:
$-6.69M
주가수익비율:
-66.73
EPS:
-0.26
순현금흐름:
$-1.84M
1주 성능:
+2.24%
1개월 성능:
+39.36%
6개월 성능:
+89.20%
1년 성능:
+405.83%
1일 변동 폭
Value
$16.43
$17.55
1주일 범위
Value
$16.43
$17.74
52주 변동 폭
Value
$3.18
$18.41

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name
명칭
Eton Pharmaceuticals Inc
Name
전화
(847) 787-7361
Name
주소
21925 W. FIELD PARKWAY, DEER PARK, IL
Name
직원
31
Name
트위터
Name
다음 수익 날짜
2025-03-18
Name
최신 SEC 제출 서류
Name
ETON's Discussions on Twitter

ETON을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ETON
Eton Pharmaceuticals Inc
17.35 455.09M 31.38M -6.69M -1.84M -0.26
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
161.92 70.37B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.19 48.41B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.71 47.91B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.96 18.80B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
310.80 13.47B 2.76B 1.11B 898.10M 22.77

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-23 재확인 H.C. Wainwright Buy
2025-01-10 개시 B. Riley Securities Buy
2025-01-06 재확인 H.C. Wainwright Buy
2024-09-04 재개 H.C. Wainwright Buy
2024-05-06 개시 Craig Hallum Buy
2021-10-14 재개 B. Riley Securities Buy
2021-01-04 재확인 H.C. Wainwright Buy
2019-09-20 개시 B. Riley FBR Buy
2019-06-10 개시 H.C. Wainwright Buy
모두보기

Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스

pulisher
10:03 AM

A Look Ahead: Eton Pharmaceuticals's Earnings Forecast - Nasdaq

10:03 AM
pulisher
May 09, 2025

Eton Pharmaceuticals Inc expected to post earnings of 5 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 08, 2025

Envestnet Asset Management Inc. Invests $236,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

May 08, 2025
pulisher
May 07, 2025

Barclays PLC Takes Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

May 07, 2025
pulisher
May 02, 2025

Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 33% - simplywall.st

May 02, 2025
pulisher
May 02, 2025

Eton Pharmaceuticals Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView

May 02, 2025
pulisher
May 01, 2025

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Eton Pharmaceuticals to Report Q1 2025 Financial Results on May 13, 2025 - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Rare Disease Leader Eton Pharmaceuticals Sets Q1 2025 Earnings Date: Key Updates Coming May 13 - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Q1 EPS Estimate for Eton Pharmaceuticals Boosted by Analyst - Defense World

May 01, 2025
pulisher
Apr 30, 2025

JPMorgan Chase & Co. Acquires 51,238 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

B. Riley Raises Earnings Estimates for Eton Pharmaceuticals - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Eton Pharmaceuticals submits NDA for its diabetes insipidus treatment - MSN

Apr 29, 2025
pulisher
Apr 28, 2025

Eton Pharmaceuticals (ETON) Submits NDA for New Treatment for Ce - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Eton Pharmaceuticals submits NDA for its diabetes insipidus treatment (ETON:NASDAQ) - Seeking Alpha

Apr 28, 2025
pulisher
Apr 28, 2025

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Eton Pharmaceuticals Says FDA Review Expected To Take 10 Months, Potential Q1 2026 Launch - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution) - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Groundbreaking Pediatric Diabetes Drug Advances: First-Ever Liquid Formulation Heads to FDA Review - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Geode Capital Management LLC Sells 4,050 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 20, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Increase in Short Interest - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability - Yahoo Finance

Apr 15, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Makes New Investment in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World

Apr 13, 2025
pulisher
Apr 09, 2025

Retail investors who have a significant stake must be disappointed along with institutions after Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) market cap dropped by US$35m - simplywall.st

Apr 09, 2025
pulisher
Apr 05, 2025

(ETON) Technical Data - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 05, 2025

Eton sells ex-U.S. rights for hormone disorder therapy to Esteve Pharma - MSN

Apr 05, 2025
pulisher
Apr 01, 2025

Eton sells overseas rights for hormone disorder drug (ETON) - Seeking Alpha

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharma Out-Licenses International Rights To Increlex To Esteve Pharma - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals out-licenses international rights to Increlex - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals IncEsteve To Pay Eur4 Million Up Front For Increlex RightsSEC Filing - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals licenses Increlex rights abroad - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals licenses Increlex rights abroad By Investing.com - Investing.com UK

Apr 01, 2025
pulisher
Apr 01, 2025

Eton Pharmaceuticals Out-Licenses International Rights to Increlex® - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Major Pharma Deal: Eton's Smart Move Unlocks Global Market for Rare Disease Treatment - Stock Titan

Apr 01, 2025
pulisher
Mar 25, 2025

Eton Pharmaceuticals Inc (ETON) Shares Down 4.87% on Mar 25 - GuruFocus

Mar 25, 2025
pulisher
Mar 25, 2025

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

REG-CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency… - Informazione.it

Mar 25, 2025
pulisher
Mar 22, 2025

Eton Pharmaceuticals Inc (ETON) Stock Price Down 3.79% on Mar 22 - GuruFocus

Mar 22, 2025
pulisher
Mar 22, 2025

Q3 EPS Estimates for Eton Pharmaceuticals Lifted by B. Riley - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Eton Pharmaceuticals’ (ETON) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Research Analysts Set Expectations for ETON Q2 Earnings - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

B. Riley Reiterates Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON) - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Q1 EPS Forecast for Eton Pharmaceuticals Boosted by Analyst - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, Craig Hallum Analyst Says - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

5 Analysts Assess Eton Pharmaceuticals: What You Need To Know - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating - MarketScreener

Mar 19, 2025

Eton Pharmaceuticals Inc (ETON) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$31.27
price up icon 3.78%
$79.52
price down icon 2.72%
$8.96
price up icon 2.17%
$120.43
price up icon 4.08%
drug_manufacturers_specialty_generic RDY
$13.93
price up icon 3.96%
$310.80
price up icon 3.11%
자본화:     |  볼륨(24시간):